Nothing Special   »   [go: up one dir, main page]

IE39830L - Cephalosporin derivatives - Google Patents

Cephalosporin derivatives

Info

Publication number
IE39830L
IE39830L IE741822A IE182274A IE39830L IE 39830 L IE39830 L IE 39830L IE 741822 A IE741822 A IE 741822A IE 182274 A IE182274 A IE 182274A IE 39830 L IE39830 L IE 39830L
Authority
IE
Ireland
Prior art keywords
gram
compounds
cephalosporin derivatives
treating
acid
Prior art date
Application number
IE741822A
Other versions
IE39830B1 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US394367A external-priority patent/US3907786A/en
Priority claimed from US05/411,559 external-priority patent/US3946000A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IE39830L publication Critical patent/IE39830L/en
Publication of IE39830B1 publication Critical patent/IE39830B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Compounds of the formula I <IMAGE> in which R denotes various heterocyclic radicals as defined in claim 1, are prepared by reacting a correspondingly substituted 7-aminocephemcarboxylic acid derivative with an appropriate cyclohexa(di)enylacetic acid. The novel compounds have valuable antibacterial effects for treating humans, mammals and poultry, especially for treating infectious diseases caused by various Gram-positive and Gram-negative bacteria. [GB1474790A]
IE1822/74A 1973-09-04 1974-09-03 7-(substituted 1-cyclohexenyl and 1,4 cyclohexadienyl-acetamido)-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids IE39830B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US394367A US3907786A (en) 1973-09-04 1973-09-04 7-{8 {60 -(2-aminomethyl-1,4-cyclohexadienyl)acetamido{9 -3-heterocyclic-thiomethyl-3-cephem-4-carboxylic acids and salts
US05/411,559 US3946000A (en) 1973-10-31 1973-10-31 7-[α-(2-Aminomethyl-1-cyclohexenyl)-acetamido]-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids

Publications (2)

Publication Number Publication Date
IE39830L true IE39830L (en) 1975-03-04
IE39830B1 IE39830B1 (en) 1979-01-03

Family

ID=27014711

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1822/74A IE39830B1 (en) 1973-09-04 1974-09-03 7-(substituted 1-cyclohexenyl and 1,4 cyclohexadienyl-acetamido)-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids

Country Status (13)

Country Link
JP (1) JPS5924158B2 (en)
CA (1) CA1037467A (en)
CH (1) CH613458A5 (en)
DE (1) DE2442302C2 (en)
DK (1) DK143941C (en)
FI (1) FI60019C (en)
FR (1) FR2242103B1 (en)
GB (1) GB1474790A (en)
HU (1) HU169170B (en)
IE (1) IE39830B1 (en)
NL (1) NL7411569A (en)
SE (1) SE423714B (en)
YU (1) YU233874A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040014499A (en) * 2001-04-19 2004-02-14 바이오퍼마 무르시아, 에스.에이. A PROCESS FOR PREPARING 3-CEPHALOSPORANIC ACID DERIVATIVES USING α-KETOACID DERIVATIVES
CN112645883B (en) * 2020-12-23 2022-10-25 天和药业股份有限公司 Preparation method of 3,6-dichloropyridazine

Also Published As

Publication number Publication date
DK143941C (en) 1982-04-13
FI60019C (en) 1981-11-10
FI256074A (en) 1975-03-05
AU7291474A (en) 1976-03-11
JPS5924158B2 (en) 1984-06-07
DK143941B (en) 1981-11-02
JPS5058089A (en) 1975-05-20
CH613458A5 (en) 1979-09-28
YU233874A (en) 1982-06-30
DE2442302A1 (en) 1975-03-06
GB1474790A (en) 1977-05-25
HU169170B (en) 1976-10-28
IE39830B1 (en) 1979-01-03
FR2242103B1 (en) 1978-07-21
DK466574A (en) 1975-05-05
FR2242103A1 (en) 1975-03-28
CA1037467A (en) 1978-08-29
FI60019B (en) 1981-07-31
SE423714B (en) 1982-05-24
DE2442302C2 (en) 1982-11-18
NL7411569A (en) 1975-03-06
SE7411146L (en) 1975-03-05

Similar Documents

Publication Publication Date Title
ES8104233A1 (en) Quinoline carboxylic acid derivatives
FI864825A (en) CEFALOSPORINDERIVAT.
IE39549L (en) Ureido-aryl cephalosporins ureido-phenylglycines
ES431497A1 (en) S-triazolo(1,5-a)pyridine derivative
IE39830L (en) Cephalosporin derivatives
AU548292B2 (en) 3-3-demethyl derivatives of istamycin b series compounds
FR2361114A1 (en) PROCESS FOR THE PREPARATION OF ANALOGUES OF CEPHALOSPORIN WITH ANTIBACTERIAL PROPERTY AND NEW PRODUCTS THUS OBTAINED
DK206888D0 (en) THIADIAZOLYLACETAMIDCEPHEM DERIVATIVE
IE44433L (en) Derivatives of thienamycin and its isomers
SE8008540L (en) N-SUBSTITUTED TIAZOLYL DERIVATIVES OF OXI-IMINO SUBSTITUTED CEPHALOSPORINES AND PROCEDURES FOR PREPARING THEREOF
IE40057B1 (en) 4-oxo-1-pyridinyl penicillin and cephalosporin derivatives
ES8602670A1 (en) 4-oxo-1,4-dihydronicotinic acid derivative
ES451449A1 (en) Penicillins
IE43666L (en) Cephalosporin derivatives.
IE44393L (en) Cephalosporin compounds.
JPS54125672A (en) Pseudomonic acid amide derivative, or its salt, and their preparation
IE42705L (en) Cephalosporin compounds.
ES8407494A1 (en) Manufacture of cefuroxime and novel intermediate therefor
JPS57171994A (en) Novel compound
GB1493949A (en) Preparation of 1,8-naphthyridine-3-carboxylic acid derivatives
JPS55167297A (en) Leucomycin derivative and its derivative
JPS5484589A (en) Carboxyl derivative of antibiotic ps-5
GB1493475A (en) Penicillins and their preparation
AU2467388A (en) Quinolinecarboxylic acid derivatives